Elisobeth M Mazoyer

Title: Elisobeth M Mazoyer: Innovator in Thrombosis Treatment

Introduction

Elisobeth M Mazoyer is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of thrombosis. His innovative approach utilizes specific components derived from milk to develop effective medicaments.

Latest Patents

Mazoyer holds a patent for a method of preventing or treating thrombosis. The invention relates to the use of .kappa.-caseinoglycopeptide or CGP, particularly from cow's, ewe's, goat's, or human milk. This composition is designed for the manufacture of a medicament aimed at preventing and/or treating thrombi. The medicament can be presented in lyophilized form intended for injection after being dissolved in a compatible solvent, or in the form of nanoparticles enclosed in capsules. This innovative application has significant implications for medical treatments related to thrombi.

Career Highlights

Throughout his career, Mazoyer has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Institut des Vaisseaux et du Sang (IVS). His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Mazoyer has collaborated with notable colleagues, including Ludovic O Drouet and Claire Bal Dit Sollier. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Elisobeth M Mazoyer is a distinguished inventor whose work in thrombosis treatment showcases the potential of innovative medical solutions. His contributions continue to influence the field and offer hope for improved therapeutic options.